Press Releases Scholar Rock Holding Corporation

Equities

SRRK

US80706P1030

Delayed Nasdaq Other stock markets 03:46:31 2024-05-28 pm EDT			5-day change	1st Jan Change
10.18 ^USD	-4.59%		-16.91%	-45.77%

May. 23	Transcript : Scholar Rock Holding Corporation Presents at UBS Obesity Therapeutics Day, May-23-2024 09:00 AM
May. 22	Scholar Rock Starts Phase 2 Trial of Apitegromab in Obesity	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Scholar Rock to Present New Data from SRK-181 Phase 1 DRAGON Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting	08:05am	BU
Scholar Rock : Investor Day Presentation	May. 22	PU
Scholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity	May. 22	BU
Scholar Rock Reports New Employee Inducement Grants under Nasdaq Listing Rule 5635(4)	May. 20	AQ
Scholar Rock to Participate in Upcoming Investor Conferences	May. 20	BU
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	May. 17	BU
Scholar Rock to Host Investor Day on May 22, 2024	May. 14	BU
Scholar Rock Reports First Quarter 2024 Financial Results and Highlights Business Progress	May. 07	BU
Scholar Rock Reports New Employee Inducement Grants under Nasdaq Listing Rule 5635(4)	Apr. 15	AQ
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Apr. 12	BU
Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress	Mar. 19	BU
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Mar. 15	BU
Scholar Rock : Corporate Presentation March 2024	Mar. 05	PU
Scholar Rock to Participate in Upcoming Investor Conferences	Feb. 28	BU
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Feb. 16	BU
Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer	Feb. 15	BU
Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management	Feb. 06	BU
Scholar Rock Announces Presentation of New Preclinical Data Evaluating SRK-439 in Obesity at Keystone Symposia	Jan. 25	BU
Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity	Jan. 23	BU
Scholar Rock Reports New Employee Inducement Grants under Nasdaq Listing Rule 5635(4)	Jan. 15	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Scholar Rock Holding Corporation

Equities

SRRK

US80706P1030

Press Releases

Filters